EUVIMEDEUVIMED entdecken
Crossref

A Comparative Study of Equipotent Doses of Intrathecal Hyperbaric Ropivacaine and Hyperbaric Levobupivacaine

Manjunatha Kolur, Mohammed Yahya, Sindhu N. Pawadigoudra

International Journal of Current Pharmaceutical Review and Research · 30.06.2026 · 18 (06)

DOI: 10.25258/ijcpr.18.6.215 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Current Pharmaceutical Review and Research, online erschienen am 30.06.2026. Verfasst von Manjunatha Kolur und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Spinal anaesthesia is widely used for lower abdominal and lower limb surgeries due to its efficacy, simplicity, and hemodynamic stability. Hyperbaric formulations of levobupivacaine and ropivacaine offer potential advantages in block characteristics and postoperative analgesia.

Objective

To compare the clinical efficacy and safety of intrathecal hyperbaric 0.5% levobupivacaine versus 0.75% ropivacaine in patients undergoing elective infraumbilical and lower limb surgeries.

Methods

This prospective, randomized, double-blind study enrolled 60 ASA I–II patients, aged 20–60 years, divided equally into two groups. Group A received 3 ml of hyperbaric 0.75% ropivacaine, and Group B received 3 ml of hyperbaric 0.5% levobupivacaine. Outcomes assessed included onset and duration of sensory and motor blockade, quality of motor block (Modified Bromage Scale), duration of postoperative analgesia, intraoperative hemodynamic changes, and adverse effects. Data were analyzed using SPSS v25, with p < 0.05 considered significant.

Results

Group B demonstrated a faster onset of sensory block at T10 (1.80 ± 0.93 min vs 3.40 ± 0.98 min, p = 0.01) and motor block (4.20 ± 1.86 min vs 6.80 ± 2.36 min, p = 0.02) compared to Group A. Sensory and motor block durations were significantly longer in Group B (113.40 ± 13.03 min vs 81.00 ± 11.06 min, p = 0.01; 171.40 ± 17.61 min vs 126.00 ± 20.94 min, p = 0.05). Postoperative analgesia was prolonged in Group B (262.00 ± 48.73 min vs 176.00 ± 31.90 min, p = 0.03), with fewer patients requiring rescue analgesia (16.7% vs 40%, p = 0.04). Hemodynamic stability and incidence of adverse effects were comparable between groups.

Conclusion

Hyperbaric 0.5% levobupivacaine provides faster onset, longer sensory and motor blockade, and prolonged postoperative analgesia compared to 0.75% ropivacaine, with comparable safety. Levobupivacaine is preferable for surgeries requiring extended spinal anaesthesia and analgesia. But Ropivacaine's lower cardiotoxicity makes it a safer alternative in patients with cardiac risk factors.

Zitieren

APA

Kolur, M., Yahya, M., & Pawadigoudra, S. N. (2026). A Comparative Study of Equipotent Doses of Intrathecal Hyperbaric Ropivacaine and Hyperbaric Levobupivacaine. International Journal of Current Pharmaceutical Review and Research, 18(06). https://doi.org/10.25258/ijcpr.18.6.215

Vancouver

Kolur M, Yahya M, Pawadigoudra SN. A Comparative Study of Equipotent Doses of Intrathecal Hyperbaric Ropivacaine and Hyperbaric Levobupivacaine. International Journal of Current Pharmaceutical Review and Research. 2026;18(06). doi:10.25258/ijcpr.18.6.215

BibTeX
@article{Kolur2026,
  author = {Kolur, Manjunatha and Yahya, Mohammed and Pawadigoudra, Sindhu N.},
  title = {A Comparative Study of Equipotent Doses of Intrathecal Hyperbaric Ropivacaine and Hyperbaric Levobupivacaine},
  journal = {International Journal of Current Pharmaceutical Review and Research},
  year = {2026},
  volume = {18},
  number = {06},
  doi = {10.25258/ijcpr.18.6.215}
}
Kostenlos starten →